The field of structural genomics aims to characterize the structure-function relationships of all proteins by the experimental elucidation of the three dimensional atomic structures of representative members of protein families combined with the accurate computation of models for closely sequence related proteins. The path from gene to structure for eukaryotic proteins is riddled with challenges including the error-prone isolation of gene clones from cDNA libraries, poor yields in protein expression and purification, and time lost between the set-up of crystallization experiments and X-ray diffraction analysis of putative crystals. To address these challenges, we propose the development of integrated instruments, methods and software that will substantially increase the success rate while reducing the time, effort, materials, and cost required for protein structure determination. Among these new developments will be: (1) Rosetta-guided design and gene synthesis of expression optimized DNA sequences encoding proteins that are guided towards more facile purification and improved crystallogenesis; (2) nano-volume microfluidic crystallization devices that embody the major protein crystallization methods allowing extensive crystallization screening of precious protein samples and their complexes; and (3) a tunable in-house MAD X-ray source which will allow in situ room-temperature crystal X-ray diffraction screening and final anomalous dispersion diffraction data collection for rapid structure determination. Starting in year 3, these new technologies will be validated through the planned structure determination and public release of over 550 eukaryotic protein targets belonging to families with high relevance to cancer biology and therapy, including kinases, transcription factors, and metabolic enzymes. The dissemination of the proposed instrumentation, methods and software will allow researchers to pursue protein X-ray crystal structures at or below a total cost of $10,000 per eukaryotic protein structure.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54GM074961-03
Application #
7256302
Study Section
Special Emphasis Panel (ZGM1-CBB-3 (SC))
Program Officer
Edmonds, Charles G
Project Start
2005-07-01
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
3
Fiscal Year
2007
Total Cost
$3,813,646
Indirect Cost
Name
Emerald Biostructures
Department
Type
DUNS #
016974144
City
Bainbridge Island
State
WA
Country
United States
Zip Code
98110
Christensen, Jeff; Gerdts, Cory J; Clifton, Mathew C et al. (2011) Salvage and storage of infectious disease protein targets in the SSGCID high-throughput crystallization pathway using microfluidics. Acta Crystallogr Sect F Struct Biol Cryst Commun 67:1022-6
Lorimer, Don; Raymond, Amy; Mixon, Mark et al. (2011) Gene Composer in a structural genomics environment. Acta Crystallogr Sect F Struct Biol Cryst Commun 67:985-91
Pompano, Rebecca R; Liu, Weishan; Du, Wenbin et al. (2011) Microfluidics using spatially defined arrays of droplets in one, two, and three dimensions. Annu Rev Anal Chem (Palo Alto Calif) 4:59-81
Li, Liang; Fu, Qiang; Kors, Christopher A et al. (2010) A Plug-Based Microfluidic System for Dispensing Lipidic Cubic Phase (LCP) Material Validated by Crystallizing Membrane Proteins in Lipidic Mesophases. Microfluid Nanofluidics 8:789-798
Pelissier, Marie-Cécile; Lesley, Scott A; Kuhn, Peter et al. (2010) Structural insights into the catalytic mechanism of bacterial guanosine-diphospho-D-mannose pyrophosphorylase and its regulation by divalent ions. J Biol Chem 285:27468-76
Li, Liang; Karymov, Mikhail A; Nichols, Kevin P et al. (2010) Dead-end filling of SlipChip evaluated theoretically and experimentally as a function of the surface chemistry and the gap size between the plates for lubricated and dry SlipChips. Langmuir 26:12465-71
Chien, Ellen Y T; Liu, Wei; Zhao, Qiang et al. (2010) Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 330:1091-5
Jaakola, Veli-Pekka; Lane, J Robert; Lin, Judy Y et al. (2010) Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residues. J Biol Chem 285:13032-44
Wacker, Daniel; Fenalti, Gustavo; Brown, Monica A et al. (2010) Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc 132:11443-5
Li, Liang; Ismagilov, Rustem F (2010) Protein crystallization using microfluidic technologies based on valves, droplets, and SlipChip. Annu Rev Biophys 39:139-58

Showing the most recent 10 out of 50 publications